Nephrocare Health Services Releases Q2 FY27 IPO Proceeds Monitoring Report
Nephrocare Health Services Ltd 路 Others (Uncategorized) 路 04 Nov 2026, 12:51 am
Nephrocare Health Services Releases Q2 FY27 IPO Proceeds Monitoring Report Crisil Ratings issued the Monitoring Agency Report for Nephrocare Health Services for the quarter ended 30th Sep'26. Out of total gross IPO proceeds of Rs 3,534.05 million, the company has utilized Rs 2,389.25 million, leaving Rs 1,144.80 million unutilized and parked in fixed deposits and bank accounts. Full planned debt repayment of Rs 1,359.99 million was achieved earlier. Capex deployment for new dialysis clinics reached Rs 187.39 million against a Rs 1,291.06 million allocation, facing implementation delays due to clinic finalization timelines.
Original exchange filing (PDF)
More announcements from Nephrocare Health Services Ltd
- We hereby inform that the Company has approved grant of ESOPs under the Scheme as per the disclosure annexed herewith. 路 17 Nov 2026
- Pursuant to Reg 30 of SEBI Listing Regulations, 2015, we hereby inform that the Company has approved allotment of 3,42,130 equity shares of Rs. 2/- each, pursuant to the exercise of stock .... 路 17 Nov 2026
- Please find enclosed herewith Transcripts for the Investors Earnings call held on November 4, 2026. 路 12 Nov 2026
- Pursuant to Reg 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an investor conference call as per the disclosure annexed herewith. 路 12 Nov 2026
- In Continuation to our letter dated October 21, 2026 please find enclosed link of the audio recording of the Investors'' Conference Call held on November 04, 2026 on the Unaudited Standalone .... 路 04 Nov 2026
- Please find investor presentation for quarter and half year ended September 30, 2026. 路 03 Nov 2026
- Press release on Unaudited standalone and consolidated financial results for quarter and half year ended September 30, 2026. 路 03 Nov 2026
- Outcome of the Board meeting held on November 3, 2026 for considering and approving the financial results for the period ended September 30, 2026. 路 03 Nov 2026
